Disclosures for "Comparing the Impact of Video Integration to Traditional Amyotrophic Lateral Sclerosis (ALS) Visit Communication on Patient and Caregiver Quality of Life (VITALS trial): Design of a Randomized Controlled Trial "
-
Dr. Yazdanian has nothing to disclose.
-
Dr. Garret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Garret has received research support from Biogen. The institution of Dr. Garret has received research support from Target ALS. The institution of Dr. Garret has received research support from uniQure. The institution of Dr. Garret has received research support from Mass General Brigham. The institution of Dr. Garret has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Garret has received research support from NIH/NINDS. Dr. Garret has received research support from FDA. Dr. Garret has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Massachusetts Department of Health.
-
Dr. Goedert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diehl Consulting Group.
-
An immediate family member of Dr. Yen has stock in Civicom, Inc.
-
Dr. Bratches has nothing to disclose.
-
Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
-
Author has nothing to disclose
-
The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Babu has received personal compensation in the range of $0-$499 for serving as a Consultant for Specific Biologics. The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure Therapeutics. The institution of Dr. Babu has received research support from Biogen. The institution of Dr. Babu has received research support from Ionis. The institution of Dr. Babu has received research support from OrphAI therapeutics. The institution of Dr. Babu has received research support from Denali Therapeutics. The institution of Dr. Babu has received research support from Tiziana. Dr. Babu has a non-compensated relationship as a Appointed Member of the Committee on ALS: Accelerating Treatments and Improving Quality of Life with National Academies of Sciences, Engineering and Medicine that is relevant to AAN interests or activities.